+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Virus Filtration Market Research and Forecast, 2019-2025

  • PDF Icon


  • April 2019
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 4770699
Global Virus Filtration Market Size, Share & Trends Analysis Report by Product (Kits and Reagents, Filtration System, and Services), by Application (Biological, Medical Devices, and Industrial Purification), by End-User (Pharmaceutical & Biotechnology Companies and Research Institutes), and Forecast, 2019-2025.

A virus is a very small molecule that is capable of infecting a cell and conceivably causing disease. The cell that is contaminated by a virus is known as a host cell. The virus can infect any living being such as human, plant, and animals and potentially causing disease. Viruses are irresistible operators or particles that are undesired, particularly in the pharmaceuticals industry. Virus filtration membranes are mainly used to purify biopharmaceutical products. There are mainly two types of membranes such as retrovirus and parvovirus filtration membranes which are used for the filtration process of the biopharmaceutical products. This provides high purity and high product concentrations. This methodology gives an industry-applicable benchmark for the engineering competence of virus filters. Asymmetric membranes work in the direct flow and in a consistent pressure mode in accordance with the industrial practice of virus filtration. However, new improvements in research and development utilizing transition strategy permit to speed up virus filtration and similar ultrafiltration membranes, which additionally give insights into designing virus filtration membranes.

The market for virus filtration is segmented on the basis of product, end-user, and application. On the basis of the product, the market is further divided as a filtration system, services, kits, and reagents. The kits and reagents segment are expected to hold a significant share in the market, by product. This is basically attributed to its convenience and its extensive use by pharmaceutical and biotechnology organization. On the basis of application, it is the market is divided into medical devices, industrial purification, biological. The biologics segment is expected to hold the biggest share in the market and it is expected to grow at the significant rate during the forecast period owing to the rise in the production of biologics and expanding government funding as well as promotional initiatives undertaken for use of biologics to treat different medical conditions. Expanding R&D innovation in various applications such as stem cell biology and gene therapy has also been contributing altogether to the development of this market. On the basis of end-user, it is divided into pharmaceutical & biotechnology companies and research institutes. On the basis of geography, it is further divided into North America, Asia-Pacific, Europe and Rest of the World.

There are various companies providing virus filtration services such as Pall Corp., Asahi Kasei Medical Co. Ltd., Sartorius AG, Thermo Fisher Scientific, Inc., Merck KGaA, and Charles River Laboratories International, Inc. These companies are providing various solution for the filtration of viruses and also innovate new product. In 2019, Sartorius Stedim Biotech (SSB) launched Virosart Media, this virus filter product offers a check for virus defilement and with this, the organization has extended its product profile. The market driving factor can be expanding pharmaceutical sector due to the adoption of technologically advanced processes for virus filtration, an increase in consumer healthcare expenditure tends to grow the market in the near future.

Research Methodology

The market study of the global virus filtration market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog

The report is intended for the Virus filtration service provider, companies, research, investment companies, government organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

Market Segmentation:
1. Global Virus filtration Market Research and Analysis by Product
2. Global Virus filtration Market Research and Analysis by Application
3. Global Virus filtration Market Research and Analysis by End-User

The Report Covers:
  • Comprehensive research methodology of the global virus filtration market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Insights about market determinants which are stimulating the global virus filtration market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders
2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Competitive Dashboard
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Pall Corp. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Merck KGaA Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. Sartorius AG Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Thermo Fisher Scientific, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. Charles River Laboratories International, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Virus Filtration Market by Product
5.1.1. Kits and Reagents
5.1.2. Filtration Systems
5.1.3. Services
5.2. Global Virus Filtration Market by Application
5.2.1. Biological
5.2.2. Medical Devices
5.2.3. Industrial Purification
5.3. Global Virus Filtration Market by End-User
5.3.1. Pharmaceutical & Biotechnology Companies
5.3.2. Research Institutes
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Agilent Technologies, Inc.
7.2. Argonide Corp.
7.3. Asahi Kasei Medical Co., Ltd.
7.4. Bio-Rad Laboratories, Inc.
7.5. Charles River Laboratories International, Inc.
7.6. Corning, Inc.
7.7. Eppendorf AG
7.8. F. Hoffmann-La Roche, Ltd.
7.9. General Electric Co.
7.10. Hospitech Manufacturing Services Sdn Bhd
7.11. Merck KGaA
7.12. Nelson Laboratories, LLC
7.13. Non-Change Enterprise Co., Ltd.
7.14. Pall Corp.
7.15. QIAGEN N.V.
7.16. Sartorius AG
7.17. Seychelle Water Filtration
7.18. TeraPore Technologies, Inc.
7.19. Texcell
7.20. Thermo Fisher Scientific, Inc.
7.21. WuXi PharmaTech (Cayman), Inc.
* List of Tables and Figures available on enquiry

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Agilent Technologies, Inc.
  • Argonide Corp.
  • Asahi Kasei Medical Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Corning, Inc.
  • Eppendorf AG
  • F. Hoffmann-La Roche, Ltd.
  • General Electric Co.
  • Hospitech Manufacturing Services Sdn Bhd
  • Merck KGaA
  • Nelson Laboratories, LLC
  • Non-Change Enterprise Co., Ltd.
  • Pall Corp.
  • Sartorius AG
  • Seychelle Water Filtration
  • TeraPore Technologies, Inc.
  • Texcell
  • Thermo Fisher Scientific, Inc.
  • WuXi PharmaTech (Cayman), Inc.